United States Paricalcitol Market Report 2018

Publisher Name :
Date: 23-Apr-2018
No. of pages: 98
Inquire Before Buying

In this report, the United States Paricalcitol market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

- The West

- Southwest

- The Middle Atlantic

- New England

- The South

- The Midwest

with sales (volume), revenue (value), market share and growth rate of Paricalcitol in these regions, from 2013 to 2025 (forecast).

United States Paricalcitol market competition by top manufacturers/players, with Paricalcitol sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

- ChemWerth Inc

- ALP Pharm Beijing Co., Ltd

- Chongqing Huapont Pharmaceutical Co. Ltd

- DISHMAN NETHERLANDS B.V.

- Haoyuan Chemexpress Co.Ltd

- Neuland Laboratories Inc

- Rochem International, Inc

- Teva Pharmaceutical Industries Ltd

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- High Purity

- Low Purity

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

- Injection Product

- Capsule Product

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Paricalcitol Market Report 2018

Table of Contents
United States Paricalcitol Market Report 2018
1 Paricalcitol Overview
1.1 Product Overview and Scope of Paricalcitol
1.2 Classification of Paricalcitol by Product Category
1.2.1 United States Paricalcitol Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Paricalcitol Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 High Purity
1.2.4 Low Purity
1.3 United States Paricalcitol Market by Application/End Users
1.3.1 United States Paricalcitol Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Injection Product
1.3.3 Capsule Product
1.4 United States Paricalcitol Market by Region
1.4.1 United States Paricalcitol Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Paricalcitol Status and Prospect (2013-2025)
1.4.3 Southwest Paricalcitol Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Paricalcitol Status and Prospect (2013-2025)
1.4.5 New England Paricalcitol Status and Prospect (2013-2025)
1.4.6 The South Paricalcitol Status and Prospect (2013-2025)
1.4.7 The Midwest Paricalcitol Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Paricalcitol (2013-2025)
1.5.1 United States Paricalcitol Sales and Growth Rate (2013-2025)
1.5.2 United States Paricalcitol Revenue and Growth Rate (2013-2025)
2 United States Paricalcitol Market Competition by Players/Suppliers
2.1 United States Paricalcitol Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Paricalcitol Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Paricalcitol Average Price by Players/Suppliers (2013-2018)
2.4 United States Paricalcitol Market Competitive Situation and Trends
2.4.1 United States Paricalcitol Market Concentration Rate
2.4.2 United States Paricalcitol Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Paricalcitol Manufacturing Base Distribution, Sales Area, Product Type
3 United States Paricalcitol Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Paricalcitol Sales and Market Share by Region (2013-2018)
3.2 United States Paricalcitol Revenue and Market Share by Region (2013-2018)
3.3 United States Paricalcitol Price by Region (2013-2018)
4 United States Paricalcitol Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Paricalcitol Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Paricalcitol Revenue and Market Share by Type (2013-2018)
4.3 United States Paricalcitol Price by Type (2013-2018)
4.4 United States Paricalcitol Sales Growth Rate by Type (2013-2018)
5 United States Paricalcitol Sales (Volume) by Application (2013-2018)
5.1 United States Paricalcitol Sales and Market Share by Application (2013-2018)
5.2 United States Paricalcitol Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities
6 United States Paricalcitol Players/Suppliers Profiles and Sales Data
6.1 ChemWerth Inc
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Paricalcitol Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 ChemWerth Inc Paricalcitol Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 ALP Pharm Beijing Co., Ltd
6.2.2 Paricalcitol Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 ALP Pharm Beijing Co., Ltd Paricalcitol Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Chongqing Huapont Pharmaceutical Co. Ltd
6.3.2 Paricalcitol Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Chongqing Huapont Pharmaceutical Co. Ltd Paricalcitol Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 DISHMAN NETHERLANDS B.V.
6.4.2 Paricalcitol Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 DISHMAN NETHERLANDS B.V. Paricalcitol Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Haoyuan Chemexpress Co.Ltd
6.5.2 Paricalcitol Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Haoyuan Chemexpress Co.Ltd Paricalcitol Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Neuland Laboratories Inc
6.6.2 Paricalcitol Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Neuland Laboratories Inc Paricalcitol Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Rochem International, Inc
6.7.2 Paricalcitol Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Rochem International, Inc Paricalcitol Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Teva Pharmaceutical Industries Ltd
6.8.2 Paricalcitol Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Teva Pharmaceutical Industries Ltd Paricalcitol Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
7 Paricalcitol Manufacturing Cost Analysis
7.1 Paricalcitol Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Paricalcitol
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Paricalcitol Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Paricalcitol Major Manufacturers in 2017
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Paricalcitol Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States Paricalcitol Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Paricalcitol Sales Volume Forecast by Type (2018-2025)
11.3 United States Paricalcitol Sales Volume Forecast by Application (2018-2025)
11.4 United States Paricalcitol Sales Volume Forecast by Region (2018-2025)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Paricalcitol
Figure United States Paricalcitol Market Size (MT) by Type (2013-2025)
Figure United States Paricalcitol Sales Volume Market Share by Type (Product Category) in 2017
Figure High Purity Product Picture
Figure Low Purity Product Picture
Figure United States Paricalcitol Market Size (MT) by Application (2013-2025)
Figure United States Sales Market Share of Paricalcitol by Application in 2017
Figure Injection Product Examples
Table Key Downstream Customer in Injection Product
Figure Capsule Product Examples
Table Key Downstream Customer in Capsule Product
Figure United States Paricalcitol Market Size (Million USD) by Region (2013-2025)
Figure The West Paricalcitol Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Paricalcitol Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Paricalcitol Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Paricalcitol Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Paricalcitol Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Paricalcitol Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Paricalcitol Sales (MT) and Growth Rate (2013-2025)
Figure United States Paricalcitol Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Paricalcitol Market Major Players Product Sales Volume (MT) (2013-2018)
Table United States Paricalcitol Sales (MT) of Key Players/Suppliers (2013-2018)
Table United States Paricalcitol Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Paricalcitol Sales Share by Players/Suppliers
Figure 2017 United States Paricalcitol Sales Share by Players/Suppliers
Figure United States Paricalcitol Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Paricalcitol Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Paricalcitol Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Paricalcitol Revenue Share by Players/Suppliers
Figure 2017 United States Paricalcitol Revenue Share by Players/Suppliers
Table United States Market Paricalcitol Average Price (USD/MT) of Key Players/Suppliers (2013-2018)
Figure United States Market Paricalcitol Average Price (USD/MT) of Key Players/Suppliers in 2017
Figure United States Paricalcitol Market Share of Top 3 Players/Suppliers
Figure United States Paricalcitol Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Paricalcitol Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Paricalcitol Product Category
Table United States Paricalcitol Sales (MT) by Region (2013-2018)
Table United States Paricalcitol Sales Share by Region (2013-2018)
Figure United States Paricalcitol Sales Share by Region (2013-2018)
Figure United States Paricalcitol Sales Market Share by Region in 2017
Table United States Paricalcitol Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Paricalcitol Revenue Share by Region (2013-2018)
Figure United States Paricalcitol Revenue Market Share by Region (2013-2018)
Figure United States Paricalcitol Revenue Market Share by Region in 2017
Table United States Paricalcitol Price (USD/MT) by Region (2013-2018)
Table United States Paricalcitol Sales (MT) by Type (2013-2018)
Table United States Paricalcitol Sales Share by Type (2013-2018)
Figure United States Paricalcitol Sales Share by Type (2013-2018)
Figure United States Paricalcitol Sales Market Share by Type in 2017
Table United States Paricalcitol Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Paricalcitol Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Paricalcitol by Type (2013-2018)
Figure Revenue Market Share of Paricalcitol by Type in 2017
Table United States Paricalcitol Price (USD/MT) by Types (2013-2018)
Figure United States Paricalcitol Sales Growth Rate by Type (2013-2018)
Table United States Paricalcitol Sales (MT) by Application (2013-2018)
Table United States Paricalcitol Sales Market Share by Application (2013-2018)
Figure United States Paricalcitol Sales Market Share by Application (2013-2018)
Figure United States Paricalcitol Sales Market Share by Application in 2017
Table United States Paricalcitol Sales Growth Rate by Application (2013-2018)
Figure United States Paricalcitol Sales Growth Rate by Application (2013-2018)
Table ChemWerth Inc Basic Information List
Table ChemWerth Inc Paricalcitol Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure ChemWerth Inc Paricalcitol Sales Growth Rate (2013-2018)
Figure ChemWerth Inc Paricalcitol Sales Market Share in United States (2013-2018)
Figure ChemWerth Inc Paricalcitol Revenue Market Share in United States (2013-2018)
Table ALP Pharm Beijing Co., Ltd Basic Information List
Table ALP Pharm Beijing Co., Ltd Paricalcitol Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure ALP Pharm Beijing Co., Ltd Paricalcitol Sales Growth Rate (2013-2018)
Figure ALP Pharm Beijing Co., Ltd Paricalcitol Sales Market Share in United States (2013-2018)
Figure ALP Pharm Beijing Co., Ltd Paricalcitol Revenue Market Share in United States (2013-2018)
Table Chongqing Huapont Pharmaceutical Co. Ltd Basic Information List
Table Chongqing Huapont Pharmaceutical Co. Ltd Paricalcitol Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Chongqing Huapont Pharmaceutical Co. Ltd Paricalcitol Sales Growth Rate (2013-2018)
Figure Chongqing Huapont Pharmaceutical Co. Ltd Paricalcitol Sales Market Share in United States (2013-2018)
Figure Chongqing Huapont Pharmaceutical Co. Ltd Paricalcitol Revenue Market Share in United States (2013-2018)
Table DISHMAN NETHERLANDS B.V. Basic Information List
Table DISHMAN NETHERLANDS B.V. Paricalcitol Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure DISHMAN NETHERLANDS B.V. Paricalcitol Sales Growth Rate (2013-2018)
Figure DISHMAN NETHERLANDS B.V. Paricalcitol Sales Market Share in United States (2013-2018)
Figure DISHMAN NETHERLANDS B.V. Paricalcitol Revenue Market Share in United States (2013-2018)
Table Haoyuan Chemexpress Co.Ltd Basic Information List
Table Haoyuan Chemexpress Co.Ltd Paricalcitol Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Haoyuan Chemexpress Co.Ltd Paricalcitol Sales Growth Rate (2013-2018)
Figure Haoyuan Chemexpress Co.Ltd Paricalcitol Sales Market Share in United States (2013-2018)
Figure Haoyuan Chemexpress Co.Ltd Paricalcitol Revenue Market Share in United States (2013-2018)
Table Neuland Laboratories Inc Basic Information List
Table Neuland Laboratories Inc Paricalcitol Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Neuland Laboratories Inc Paricalcitol Sales Growth Rate (2013-2018)
Figure Neuland Laboratories Inc Paricalcitol Sales Market Share in United States (2013-2018)
Figure Neuland Laboratories Inc Paricalcitol Revenue Market Share in United States (2013-2018)
Table Rochem International, Inc Basic Information List
Table Rochem International, Inc Paricalcitol Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Rochem International, Inc Paricalcitol Sales Growth Rate (2013-2018)
Figure Rochem International, Inc Paricalcitol Sales Market Share in United States (2013-2018)
Figure Rochem International, Inc Paricalcitol Revenue Market Share in United States (2013-2018)
Table Teva Pharmaceutical Industries Ltd Basic Information List
Table Teva Pharmaceutical Industries Ltd Paricalcitol Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Teva Pharmaceutical Industries Ltd Paricalcitol Sales Growth Rate (2013-2018)
Figure Teva Pharmaceutical Industries Ltd Paricalcitol Sales Market Share in United States (2013-2018)
Figure Teva Pharmaceutical Industries Ltd Paricalcitol Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Paricalcitol
Figure Manufacturing Process Analysis of Paricalcitol
Figure Paricalcitol Industrial Chain Analysis
Table Raw Materials Sources of Paricalcitol Major Players/Suppliers in 2017
Table Major Buyers of Paricalcitol
Table Distributors/Traders List
Figure United States Paricalcitol Sales Volume (MT) and Growth Rate Forecast (2018-2025)
Figure United States Paricalcitol Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Paricalcitol Price (USD/MT) Trend Forecast (2018-2025)
Table United States Paricalcitol Sales Volume (MT) Forecast by Type (2018-2025)
Figure United States Paricalcitol Sales Volume (MT) Forecast by Type (2018-2025)
Figure United States Paricalcitol Sales Volume (MT) Forecast by Type in 2025
Table United States Paricalcitol Sales Volume (MT) Forecast by Application (2018-2025)
Figure United States Paricalcitol Sales Volume (MT) Forecast by Application (2018-2025)
Figure United States Paricalcitol Sales Volume (MT) Forecast by Application in 2025
Table United States Paricalcitol Sales Volume (MT) Forecast by Region (2018-2025)
Table United States Paricalcitol Sales Volume Share Forecast by Region (2018-2025)
Figure United States Paricalcitol Sales Volume Share Forecast by Region (2018-2025)
Figure United States Paricalcitol Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Calming and Sleeping Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 17-Oct-2018        Price: US 3480 Onwards        Pages: 132
    Calming and sleeping products reduce tension and anxiety by inducing sedatives and a hypnotic effect on the body. They act by depressing the central nervous system. Scope of the Report: This report focuses on the Calming and Sleeping in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. They are used to tr......
  • Global Glycinates Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 17-Oct-2018        Price: US 3480 Onwards        Pages: 137
    Glycine is an amino acid of endogenous antioxidant reductive glutathione. It is often added exogenously in severe stress, sometimes called semi-essential amino acid. Scope of the Report: This report focuses on the Glycinates in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The feed additive segment is ......
  • Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 35
    Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline Review, H2 2018 Summary Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Aurora Kinase C is a member of the Aurora sub......
  • Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Beta or PIK3CB or EC 2.7.1.153) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 74
    Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Beta or PIK3CB or EC 2.7.1.153) - Pipeline Review, H2 2018 Summary Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Beta or PIK3CB or EC 2.7.1.153) pipeline Target constitutes close to 15 molecules. Out of which app......
  • Transforming Growth Factor Beta 2 (BSC1 Cell Growth Inhibitor or Cetermin or Glioblastoma Derived T Cell Suppressor Factor or Polyergin or TGFB2) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 50
    Transforming Growth Factor Beta 2 (BSC1 Cell Growth Inhibitor or Cetermin or Glioblastoma Derived T Cell Suppressor Factor or Polyergin or TGFB2) - Pipeline Review, H2 2018 Summary Transforming Growth Factor Beta 2 (BSC1 Cell Growth Inhibitor or Cetermin or Glioblastoma Derived T Cell Suppressor Factor or Polyergin or TGFB2) - Transforming growth factor beta 2 (TGF-ß2) is a polypeptide member of the transforming growth factor beta superfamily of cytokines encoded by......
  • Transforming Growth Factor Beta 1 (TGFB1) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 73
    Transforming Growth Factor Beta 1 (TGFB1) - Pipeline Review, H2 2018 Summary Transforming Growth Factor Beta 1 (TGFB1) pipeline Target constitutes close to 22 molecules. Out of which approximately 15 molecules are developed by companies and remaining by the universities/institutes. The latest report Transforming Growth Factor Beta 1- Pipeline Review, H2 2018, outlays comprehensive information on the Transforming Growth Factor Beta 1 (TGFB1) targeted therapeutics, co......
  • Beta Secretase 1 (Aspartyl Protease 2 or Beta Site Amyloid Precursor Protein Cleaving Enzyme 1 or Memapsin 2 or Membrane Associated Aspartic Protease 2 or BACE1 or EC 3.4.23.46) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 69
    Beta Secretase 1 (Aspartyl Protease 2 or Beta Site Amyloid Precursor Protein Cleaving Enzyme 1 or Memapsin 2 or Membrane Associated Aspartic Protease 2 or BACE1 or EC 3.4.23.46) - Pipeline Review, H2 2018 Summary Beta Secretase 1 (Aspartyl Protease 2 or Beta Site Amyloid Precursor Protein Cleaving Enzyme 1 or Memapsin 2 or Membrane Associated Aspartic Protease 2 or BACE1 or EC 3.4.23.46) - Beta-secretase 1 (BACE1) is an enzyme that in humans is encoded by the BACE1 ......
  • Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 73
    Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Review, H2 2018 Summary According to the recently published report 'Lysosomal Alpha Glucosidase - Pipeline Review, H2 2018'; Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) pipeline Target constitutes close to 16 molecules. Out of which approximately 13 molecules are developed by companies and remaining by the universities/institutes......
  • Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 56
    Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2018 Summary Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) pipeline Target constitutes close to 17 molecules. Out of which approximately 12 molecules are developed by companies and remaining by the universities/institutes. The latest report Glycogen Synthase Kinase 3 Be......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs